Founded 2006. £100m AUM Cambridge Enterprise Ventures (CEV) fund. In 2023–24: £6.5m invested in 41 transactions, formed 25 companies. Portfolio: 174 companies, £104m total value. Notable investments: 8power (sensors/IoT), Accelerated Materials (nanomaterials), CellCentric (cancer biotech), Cambridge Touch Technologies, Riverlane (quantum).
Investment Focus
Investment Thesis
Commercialisation of academic research. Pre-seed to seed spinouts from Cambridge University with breakthrough technologies or founder ties. Life sciences, physical sciences, sustainability sectors. Invests across life sciences, physical sciences, sustainability and social ventures. Recent cheque sizes range £20k-£500k. Syndicates with external co-investors at seed stage; leverages network of advisors & mentors for added value support. University-only focus: staff, students, alumni.
Interested in connecting?
Visit their website or reach out directly.